Table of Contents

January 1996; 45 (1)

Select this article
- S Ghosh and
- N J Schork
Genetic analysis of NIDDM. The study of quantitative traits.
Diabetes January 1996 45:1-14; doi:10.2337/diabetes.45.1.1
- Abstract
Select this article
- C J Tack,
- P Smits,
- J J Willemsen,
- J W Lenders,
- T Thien,
- and J A Lutterman
Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
Diabetes January 1996 45:15-22; doi:10.2337/diabetes.45.1.15
- Abstract
Select this article
- A Leturque,
- M Loizeau,
- S Vaulont,
- M Salminen,
- and J Girard
Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.
Diabetes January 1996 45:23-27; doi:10.2337/diabetes.45.1.23
- Abstract
Select this article
- T S Tsao,
- R Burcelin,
- E B Katz,
- L Huang,
- and M J Charron
Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Diabetes January 1996 45:28-36; doi:10.2337/diabetes.45.1.28
- Abstract
Select this article
- R H Skelly,
- G T Schuppin,
- H Ishihara,
- Y Oka,
- and C J Rhodes
Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line.
Diabetes January 1996 45:37-43; doi:10.2337/diabetes.45.1.37
- Abstract
Select this article
- P Mahadevan,
- R G Larkins,
- J R Fraser,
- and M E Dunlop
Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes.
Diabetes January 1996 45:44-50; doi:10.2337/diabetes.45.1.44
- Abstract
Select this article
- M L Lawson,
- E B Sochett,
- P G Chait,
- J W Balfe,
- and D Daneman
Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM.
Diabetes January 1996 45:51-55; doi:10.2337/diabetes.45.1.51
- Abstract
Select this article
- S Yagihashi,
- S Yamagishi,
- R Wada,
- K Sugimoto,
- M Baba,
- H G Wong,
- J Fujimoto,
- C Nishimura,
- and Y Kokai
Galactosemic neuropathy in transgenic mice for human aldose reductase.
Diabetes January 1996 45:56-59; doi:10.2337/diabetes.45.1.56
- Abstract
Select this article
- R W Stevenson,
- R K McPherson,
- L M Persson,
- P E Genereux,
- A G Swick,
- J Spitzer,
- J J Herbst,
- K M Andrews,
- D K Kreutter,
- and E M Gibbs
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
Diabetes January 1996 45:60-66; doi:10.2337/diabetes.45.1.60
- Abstract
Select this article
- N J Baeza,
- C I Moriscot,
- W P Renaud,
- H Okamoto,
- C G Figarella,
- and B H Vialettes
Pancreatic regenerating gene overexpression in the nonobese diabetic mouse during active diabetogenesis.
Diabetes January 1996 45:67-70; doi:10.2337/diabetes.45.1.67
- Abstract
Select this article
- A Shimada,
- P Rohane,
- C G Fathman,
- and B Charlton
Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse.
Diabetes January 1996 45:71-78; doi:10.2337/diabetes.45.1.71
- Abstract
Select this article
- R O Estacio,
- E E Wolfel,
- J G Regensteiner,
- B Jeffers,
- E P Havranek,
- S Savage,
- and R W Schrier
Effect of risk factors on exercise capacity in NIDDM.
Diabetes January 1996 45:79-85; doi:10.2337/diabetes.45.1.79
- Abstract
Select this article
- G D Baura,
- D M Foster,
- K Kaiyala,
- D Porte, Jr,
- S E Kahn,
- and M W Schwartz
Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs.
Diabetes January 1996 45:86-90; doi:10.2337/diabetes.45.1.86
- Abstract
Select this article
- A C Moses,
- S C Young,
- L A Morrow,
- M O'Brien,
- and D R Clemmons
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.
Diabetes January 1996 45:91-100; doi:10.2337/diabetes.45.1.91
- Abstract
Select this article
- G De Filippo,
- J C Carel,
- C Boitard,
- and P F Bougnères
Long-term results of early cyclosporin therapy in juvenile IDDM.
Diabetes January 1996 45:101-104; doi:10.2337/diabetes.45.1.101
- Abstract
Select this article
- A G Nugent,
- C McGurk,
- J R Hayes,
- and G D Johnston
Impaired vasoconstriction to endothelin 1 in patients with NIDDM.
Diabetes January 1996 45:105-107; doi:10.2337/diabetes.45.1.105
- Abstract

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Genetic analysis of NIDDM. The study of quantitative traits.

Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.

Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.

Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.

Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line.

Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes.

Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM.

Galactosemic neuropathy in transgenic mice for human aldose reductase.

The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.

Pancreatic regenerating gene overexpression in the nonobese diabetic mouse during active diabetogenesis.

Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse.

Effect of risk factors on exercise capacity in NIDDM.

Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs.

Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes.

Long-term results of early cyclosporin therapy in juvenile IDDM.

Impaired vasoconstriction to endothelin 1 in patients with NIDDM.

This Issue

Current Issue